Ledger.Open graph →
SEC Form D · filed October 11, 2023

Evofem Biosciences, Inc

Offering
$2.9M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Kim Kamdar · San Diego, CADirectorColin Rutherford · San Diego, CADirectorSaundra Pelletier · San Diego, CAExec · DirectorLisa Rarick · San Diego, CADirectorIvy Zhang · San Diego, CAExecTony O'Brien · San Diego, CADirectorIvy Zhang · San Diego, CAExecColin Rutherford · San Diego, CADirectorKim Kamdar · San Diego, CADirectorLisa Rarick · San Diego, CADirectorSaundra Pelletier · San Diego, CAExec · DirectorTony O'Brien · San Diego, CADirectorGian Fulgoni · Winston-Salem, NCDirectorEric Elert · Winston-Salem, NCExecDennis Lau · Bay Shore, NYExec · DirectorRegula M. Schegg · Singapore, U0DirectorWolfgang M. Hafenmayer · Singapore, U0DirectorErnesto I. Hanhausen · Singapore, U0Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗